Beyond The Numbers: 7 Analysts Discuss Capricor Therapeutics Stock
Beyond The Numbers: 7 Analysts Discuss Capricor Therapeutics Stock
超越数字：7位分析师讨论Capricor Therapeutics股票
A comprehensive examination of how...Ratings for Capricor Therapeutics (NASDAQ:CAPR) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，7位分析师对Capricor Therapeutics（纳斯达克：CAPR）的评级展示了看好和看淡的观点组合。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下面的表格显示了过去30天里情绪的变化，并将其与之前的月份进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $53.71, a high estimate of $77.00, and a low estimate of $30.00. This upward trend is evident, with the current average reflecting a 3.69% increase from the previous average price target of $51.80.
分析师通过对12个月价格目标的评估提供更深入的见解，显示出平均目标为53.71美元，高估计为77.00美元，低估计为30.00美元。这一上升趋势显而易见，目前的平均值反映出比之前的平均价格目标51.80美元增长了3.69%。
Decoding Analyst Ratings: A Detailed Look
Decoding Analyst Ratings: A Detailed Look
A comprehensive examination of how...
对财务专家...
登录免费看全文
登录/注册
资讯热榜
更新时间